MED-causing COL9A3 exon-skipping mutations were first found to be associated with a mild myopathy phenotype, characterised by proximal muscle weakness and mild to moderate elevations in serum creatine kinase (CK) levels, which is a marker of muscle damage [22]. This evidence concerns the gene COL9A3 and myopathy.